Blockers of tumour necrosis factor-α: mechanisms of action

Piotr Eder; Liliana Łykowska-Szuber; Kamila Stawczyk-Eder; Iwona Krela-Kaźmierczak; Krzysztof Linke

doi:10.5114/pg.2011.25377

eISSN: 1897-4317
ISSN: 1895-5770

Gastroenterology Review/Przegląd Gastroenterologiczny

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

5/2011
vol. 6

Send email

Copy url:

abstract:

Review paper

Blockers of tumour necrosis factor-α: mechanisms of action

Piotr Eder

,

Liliana Łykowska-Szuber

,

Kamila Stawczyk-Eder

,

Iwona Krela-Kaźmierczak

,

Krzysztof Linke

Przegląd Gastroenterologiczny 2011; 6 (5): 290–298

DOI: https://doi.org/10.5114/pg.2011.25377

Online publish date: 2011/11/11

View full text Get citation

PlumX metrics:

Inflammatory bowel diseases belong to a group of chronic inflammatory disorders. These disorders can be treated by using biological therapy, such as TNF inhibitors – TNF-α blockers, which have been in use for several years. Despite growing expertise in using these drugs, the molecular mechanisms which determine their efficiency are still not fully explained. In this paper we present the current status of this topic and we try to indicate its clinical implications

keywords:

Blockers of tumour necrosis factor-α: mechanisms of action

Piotr Eder , Liliana Łykowska-Szuber , Kamila Stawczyk-Eder , Iwona Krela-Kaźmierczak , Krzysztof Linke

inflammatory bowel diseases, anti-TNF-α agents, cytokines, cytotoxicity, apoptosis

Piotr Eder

,

Liliana Łykowska-Szuber

,

Kamila Stawczyk-Eder

,

Iwona Krela-Kaźmierczak

,

Krzysztof Linke